APRE — Aprea Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Aprea Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	130	89	53.1	28.8	21.6
Prepaid Expenses
Total Current Assets	133	92.4	56.6	30.2	22.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.563	0.359	0.21	0.002	0.088
Other Long Term Assets
Total Assets	134	92.8	56.8	30.2	22.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.06	15.3	7.32	3.2	4.39
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	9.36	15.4	7.32	3.2	4.39
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	124	77.4	49.5	27	18.3
Total Liabilities & Shareholders' Equity	134	92.8	56.8	30.2	22.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding